Cardiac mortality · patients with acute myocardial infarction
Lidocaine showed no clear difference in cardiac mortality compared with placebo or no intervention (low certainty).
1 finding from 1 review
Cardiac mortality · patients with myocardial infarction
It is very uncertain whether lidocaine changes cardiac mortality compared with mexiletine (very low certainty).
1 finding from 1 review
Cardiac mortality · patients with myocardial infarction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiac mortality · patients with myocardial infarction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiac mortality · patients with myocardial infarction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiac mortality · patients with myocardial infarction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiac mortality · patients with myocardial infarction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiac mortality · patients with myocardial infarction
It is very uncertain whether lidocaine changes cardiac mortality compared with disopyramide (very low certainty).
1 finding from 1 review
All‐cause mortality · non‐hospitalised individuals with COVID‐19 (asymptomatic and mild disease)
Anticoagulant showed no clear difference in all‐cause mortality compared with placebo or no treatment (low certainty).
1 finding from 1 review
All‐cause mortality · non‐hospitalised individuals with COVID‐19 (asymptomatic and mild disease)
1 finding from 1 review
All‐cause mortality · non‐hospitalised individuals with COVID‐19 (asymptomatic and mild disease)
1 finding from 1 review
All‐cause mortality · patients with chronic obstructive pulmonary disease
1 finding from 1 review
All‐cause mortality · patients with chronic obstructive pulmonary disease
1 finding from 1 review
All‐cause mortality · patients with chronic obstructive pulmonary disease
1 finding from 1 review
All‐cause mortality · people with haematological disorders undergoing intensive chemotherapy or stem cell transplantation
1 finding from 1 review
no estimate extracted
4 participants
GRADE not reported
All‐cause mortality · People with chronic bone marrow failure
It is very uncertain whether thrombopoietin mimetic changes all‐cause mortality compared with placebo (very low certainty).
1 finding from 1 review
Intervention not reported
All cause mortality · cancer patients receiving myelotoxic chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
All cause mortality · cancer patients receiving myelotoxic chemotherapy
1 finding from 1 review
All‐cause mortality · patients with acute myocardial infarction
Lidocaine showed no clear difference in all‐cause mortality compared with placebo or no intervention (low certainty).
1 finding from 1 review
All‐cause mortality · patients with myocardial infarction
It is very uncertain whether lidocaine changes all‐cause mortality compared with tocainide (very low certainty).
1 finding from 1 review